Press Room

Press Clipping / Nov 16, 2018

Employee focus on ethical issues keeps firms on a righteous path

Irish Examiner, November 16, 2018

This year, a further seven companies were recertified to the standard: Boots Retail, CRH, Deloitte, ESB, Gas Networks Ireland, Intel and KBC Bank Ireland.

In all, 33 companies have now achieved the BWR mark, which is hosted by Business in the Community Ireland (BITCI), which assesses applicant companies’ sustainability and corporate social responsibility commitments.

Significantly, this year’s event also saw 43 companies pledge to cut their carbon emissions between now and 2030. The signatories are in retail, manufacturing, agri-food, professional services, banks, transport and ICT.

It is becoming increasingly important for Irish companies to measure and prove their commitments to sustainability, the environment and engagement with employees and local communities. And nudging those commitments on are their existing and prospective new employees, who are becoming increasingly insistent on working in a caring workplace.

“We look at companies’ activities across the board, across their various management practices,” said BITCI’s CEO, Tomás Sercovich.

The companies speak very highly of the mark, and that is because we are very thorough about the audit process. We have 22 auditors who conduct best-in-class audits. Companies find it useful to have a third party come in to observe their policies in practice

“The truth is that companies are also very good at using this mark as a way of differentiating themselves in an increasingly complicated employment market. I know there are people working in life sciences who changing jobs, some just crossing the road to take work with a competitor.” In many cases, the employees are citing ethical grounds when changing jobs. Mr Sercovich said many new graduates are now asking companies policy questions about plastic, recycling and carbon footprint at interviews.

In the case of Cork Harbour industries, would-be employees are asking about any impacts on the harbour. In retail, companies are also becoming more attuned to the ethical antennae of their employees. One Dutch supermarket recently introduced a plastic-free aisle.

“Millennials in particular are looking to work with companies who have deep commitments across a range of issues,” Mr Sercovich said. “They’re digging deep with their questions. They won’t accept a box-ticking exercise, they want companies with real values integrated into their business models and their everyday activities.” This is where BITCI’s support is so important to companies. Going for the BWR mark is not without its risks. Attaining the mark is really demanding, so there is a very real risk of being embarrassed by falling short. Several recipients said they were relieved as well as delighted.

“We’re extremely proud to have achieved the Business Working Responsibly mark,” said Maarten Schuurman, managing director, Heineken Ireland. “It’s wonderful to see the emphasis we place on sustainability and responsibility across all aspects of our business recognised and benchmarked independently.

“The mark serves as a clear signal to our stakeholders and our customers and consumers that we are listening; that we know sustainability matters to them as much as it does to us; and that we are working every day to make Heineken Ireland a truly green brewer.” Kathryn D’Arcy, Heineken’s director of corporate affairs, added: “Our commitment to sustainability and the environment is a long journey. We need to make decisions today that will have a positive impact on the world for the people who are coming behind us.

“Heineken has built up a proud heritage over 160 years. We’re producers of premium beers and ciders. Using only quality sustainable ingredients is at the heart of what we do. The Business Working Responsibly mark is a useful part of our journey. We want our heritage and commitments to be around for another 160 years.”

Meanwhile, Hovione in Ringaskiddy is another of this year’s four new companies to achieve the Business Working Responsibly mark. It is also one of those to have signed up to BITCI’s dedicated pledge to significantly reduce their carbon emissions.

“The award fits in well with our commitment to operating sustainably,” said Paul Downing, general manager of Hovione. “We have done a lot of work in managing our carbon footprint.

Achieving the Business Working Responsibly mark is important to us, and we will be celebrating the award with our staff and the on-site team dedicated to managing this for us. The mark is also important in terms of attracting and retaining talented employees

Dr. Downing said it is increasingly a feature for job candidates to ask about companies’ commitments to the environment, their employees and their local community. Membership of BITCI is one useful measure for demonstrating Hovione’s commitments.

“People joining the company frequently ask questions about our corporate social responsibility programme,” said Mr Downing. “The Business Working Responsibly mark is a very useful measure of our environmental and community commitments.”

Hovione is also the first chemical or pharmaceutical company to become B Corp certified. B Corp is a global community of companies committed to collectively solving social and environmental problems.

 

Read the entire article

 

 

Also in the Press Room

See All

Key Takeaways Commissioning a US-based ConsiGma CDC Flex line enables end-to-end spray drying-to-tablet manufacture within a single site and quality system, reducing comparability and technology-transfer burdens. Elimination of conventional scale-up is enabled by using the same equipment from early development through commercial supply, minimizing engineering runs and conserving scarce API. Operational flexibility spans batch or continuous modes and 1–200 kg/h throughput, with scale adjustment achieved by switching continuous blenders rather than replatforming processes. High-containment design to 1 µg/m³ expands suitability for highly potent oral solid-dose programs while maintaining integrated development-to-commercial workflows. Regulatory momentum for continuous manufacturing is supported by ICH Q13 harmonization, increasing FDA approvals, and platforms leveraging inline PAT and automated control suites for real-time quality assurance. Hovione announced on Oct. 5, 2026, that it will commission the ConsiGma CDC Flex, a next-generation continuous direct compression tableting platform jointly developed with GEA. The investment is designed to link amorphous solid dispersion manufacturing via spray drying with commercial tablet production at a single US site operating under one quality system. The line will run in either continuous or batch mode at throughputs from 1 to 200 kg/h. Formulation development can begin with as little as 1.5 kg of material, and the same equipment can then support everything from very small clinical batches to large commercial runs, enabled by a design that allows the system to switch between continuous blenders of different sizes. The installation will also be contained to 1 µg/m³ to accommodate highly potent compounds. "Hovione will be the first company in the world to offer the ConsiGma® CDC Flex, bringing this next-generation technology with unprecedented flexibility, simplicity and cost-efficiency in continuous tableting," said Marco Gil and António Almeida, co-CEOs, Hovione, said in a press release. "This investment also advances our strategy of building integrated capabilities close to customers in key markets. By adding this new line at East Windsor, we are broadening access to this technology in the U.S. and giving customers a more direct and accelerated path for developing and commercializing complex oral medicines." What Does a Single Development-To-Commercial Line Change? For formulators and process engineers, the most consequential claim is the removal of traditional scale-up. Moving a process from development equipment to commercial equipment typically requires engineering runs, bridging work, and consumption of scarce API, all of which weigh heavily on early programs with limited material. "Installing the CDC Flex at 89 Twin Rivers makes continuous tableting part of an integrated US development and manufacturing workflow," said David Basile, Vice President of Technical Operations, Hovione, in the press release. "Customers can move from formulation and particle engineering to commercial tablets with one Hovione team and one quality system, eliminating traditional scale-up while gaining greater production flexibility, process control and supply continuity." Co-locating spray drying and tableting is also significant because amorphous solid dispersions remain a primary solubility-enhancement route for poorly soluble molecules, and transferring intermediates between sites or vendors adds technology transfer and comparability burdens. The new line builds on the company's earlier US expansion; Hovione recently completed a $100 million investment to bolster US capacity in particle design, amorphous solid dispersions via spray drying, and batch and continuous tableting. How Is the Regulatory Environment Shaping Continuous Tableting Adoption? The company points to the 2022 adoption of ICH Q13, which provides harmonized guidance for continuous manufacturing of drug substances and drug products across the US, Europe, and Japan. Hovione reports that, as of 2024, FDA alone had approved 17 products manufactured under the guidance. Speaking on ICH Q13, FDA's Kelley Burridge, PhD, "Perceived barriers to continuous manufacturing have been falling one by one," and noted an FDA publication showing faster approval times for products with continuous manufacturing elements than for comparable batch products. The platform incorporates inline process analytical technology and automated controls for real-time quality monitoring, along with SimpleCT, an automation and control suite intended to support a single process from development through commercial supply. For sponsors weighing supply resilience and regional sourcing, the East Windsor installation extends a capability that Hovione says only it currently offers as a contract development and manufacturing organization.   Read the full article at PharmTech.com  

Press Clipping

Can Continuous Tableting End Scale-Up for Complex Oral Drugs?

Oct 05, 2026

The company is building out more than 200,000 square feet of space in New Jersey. In April, Contract Pharma had the opportunity to tour Hovione’s expanded manufacturing facility in East Windsor, NJ. The company is planning a formal ribbon-cutting this fall; before that, we got an inside look at some new features. Having established United States operations in 2002, Hovione now has more than 200,000 square feet of space in New Jersey. This will be developed into a large, integrated campus in the next five to ten years. Overall, the company’s recent NJ expansion, which began in 2025, has tripled its total spray-drying capacity in the U.S. Future Facility Upgrades A 125,000-square-foot greenfield acquired by Hovione at the East Windsor campus will eventually be a large-scale production site. This includes enhanced quality control and R&D capabilities. Together, all this adds to Hovione’s stable of manufacturing sites, R&D centers, and other offices spread across three continents. Key to the expansion is a targeted reduction of Hovione’s carbon footprint by 40% by the year 2030. Part of this goal is embracing new and/or changing solvent types to help meet sustainability standards. Additionally, the company says automation that has been put in place at its Portugal site will be replicated in NJ. Hovione Aligns NJ Operations At the Drug, Chemical & Associated Technologies Association (DCAT) Week in New York in March, Contract Pharma met with Hovione. There, David Basile, Vice President of Technical Operations—Americas, further illustrated the New Jersey expansion. “Hovione aims to build an equivalent manufacturing network, where clients can go to any site across the globe,” Basile said. “The design of the facility has been well-thought through with material flows [and] gravity-fed processes. It’s scalable. We call each one of these building segments a finger. You can copy and paste these fingers, and they are built to house both spray drying and drug product assets.” Ultimately, with these moves and a strategic partnership model, Hovione aims to provide customers an opportunity to co-invest and access the company’s proprietary knowledge and assets to accelerate programs and create long-term value. Read the full article at ContractPharma.com    

Press Clipping

Hovione Planning Ribbon-Cutting at NJ Facility – A Behind-the-Scenes Preview

Jul 31, 2026